Search 

Dr. Sasiela is the Regulatory Specialist for the Office of Translational Alliances and Coordination (OTAC, http://bit.ly/callNHLBIotac) of the National Heart, Lung, and Blood Institute (NHLBI).  In this role she helps NHLBI-funded investigators (academic and small businesses) understand and navigate the US biomedical regulatory pathway through educational events and one-on-one consultation.  Prior to joining the NHLBI, Chris’ regulatory experience includes working in the Office of Biotechnology Products at the FDA, and as Director of Regulatory Affairs and Services at a contracting company.  She earned a Bachelor’s degree in Chemistry from Whittier College; a Ph.D. in Pharmaceutical Science from the University of Maryland Baltimore; and holds a Regulatory Affairs Certification (US) through the Regulatory Affairs Professional Society.

As a program director in the Division of Kidney, Urologic, and Hematologic Diseases of the National Institute of Diabetes and Digestive and Kidney Diseases, Daniel's portfolio includes research conducted by small businesses (SBIR & STTR), technology development efforts, and translational research in the areas of kidney, urologic, and hematologic diseases.

Ms. Fertig manages the small business programs (SBIR and STTR) at the National Institute of Neurological Disorders and Stroke (NINDS).

Information about funding opportunities can be found at ninds.nih.gov/otr